Gabriel Heinz, Stumm Markus
Zentrum für Humangenetik Tübingen, Tübingen, Germany.
Medicover Humangenetik Berlin-Lichtenberg MVZ, Berlin, Germany.
Geburtshilfe Frauenheilkd. 2025 Jul 11;85(9):934-940. doi: 10.1055/a-2567-3396. eCollection 2025 Sep.
Prenatal diagnostics are used to identify the causes of fetal anomalies detected on ultrasound. If ultrasound findings appear to indicate a genetic disorder, sequencing methods offer the opportunity to safely diagnose numerous genetic disorders prenatally with the help of diagnostic puncture and aspiration. Depending on the type of ultrasound abnormality, massive parallel sequencing (MPS) (the terms "high throughput sequencing" and "next generation sequencing" [NGS] are often used synonymously) can identify up to 50% of the causes of fetal malformations (skeletal abnormalities). Confirmation of a genetic disorder makes it possible to inform and advise pregnant women or parents who are looking for advice about the expected development of their unborn child and provides a science-based assessment of the risk of recurrence. This review article describes the benefits and special features of prenatal diagnostic tests using next generation sequencing and looks ahead at the developments in molecular genetic diagnostic procedures which may be used for the prenatal confirmation of genetic disorders in the future.
产前诊断用于确定超声检查发现的胎儿异常的原因。如果超声检查结果似乎表明存在遗传疾病,测序方法提供了借助诊断性穿刺和抽吸在产前安全诊断多种遗传疾病的机会。根据超声异常的类型,大规模平行测序(MPS)(术语“高通量测序”和“下一代测序”[NGS]经常同义使用)可识别高达50%的胎儿畸形(骨骼异常)原因。遗传疾病的确诊能够为寻求有关未出生胎儿预期发育建议的孕妇或父母提供信息和建议,并基于科学对复发风险进行评估。这篇综述文章描述了使用下一代测序进行产前诊断测试的益处和特点,并展望了未来可能用于产前确诊遗传疾病的分子遗传诊断程序的发展。